Joseph Sakai
Concepts (318)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conduct Disorder | 29 | 2025 | 188 | 8.860 |
Why?
| | Substance-Related Disorders | 31 | 2025 | 1133 | 3.990 |
Why?
| | Adolescent Behavior | 10 | 2025 | 545 | 3.360 |
Why?
| | Emotions | 13 | 2025 | 586 | 3.210 |
Why?
| | Empathy | 10 | 2025 | 181 | 3.130 |
Why?
| | Antisocial Personality Disorder | 14 | 2025 | 153 | 2.730 |
Why?
| | Theory of Mind | 3 | 2025 | 15 | 2.570 |
Why?
| | Psychiatry | 5 | 2026 | 193 | 1.670 |
Why?
| | Executive Function | 3 | 2025 | 465 | 1.450 |
Why?
| | Cognition | 6 | 2025 | 1271 | 1.410 |
Why?
| | Cannabis | 5 | 2025 | 521 | 1.340 |
Why?
| | Morals | 2 | 2023 | 81 | 1.250 |
Why?
| | Students, Medical | 4 | 2023 | 380 | 1.170 |
Why?
| | Mental Disorders | 9 | 2025 | 1167 | 1.160 |
Why?
| | Adolescent | 50 | 2025 | 22670 | 1.110 |
Why?
| | Risk-Taking | 8 | 2023 | 343 | 1.100 |
Why?
| | Social Behavior | 2 | 2025 | 294 | 1.080 |
Why?
| | Helping Behavior | 2 | 2019 | 20 | 1.060 |
Why?
| | Brain | 11 | 2025 | 2909 | 0.950 |
Why?
| | Connectome | 2 | 2023 | 91 | 0.910 |
Why?
| | Affect | 2 | 2025 | 319 | 0.900 |
Why?
| | Altruism | 2 | 2023 | 28 | 0.900 |
Why?
| | Medical Marijuana | 3 | 2017 | 125 | 0.850 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2010 | 68 | 0.820 |
Why?
| | Career Mobility | 1 | 2024 | 70 | 0.820 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 137 | 0.820 |
Why?
| | Clinical Clerkship | 2 | 2023 | 114 | 0.810 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 580 | 0.810 |
Why?
| | Awards and Prizes | 1 | 2024 | 72 | 0.800 |
Why?
| | Psychology, Adolescent | 2 | 2016 | 69 | 0.770 |
Why?
| | Alcoholism | 11 | 2014 | 846 | 0.770 |
Why?
| | Binge Drinking | 1 | 2023 | 46 | 0.750 |
Why?
| | Cerebral Cortex | 5 | 2017 | 464 | 0.700 |
Why?
| | Models, Psychological | 1 | 2023 | 313 | 0.700 |
Why?
| | Motivation | 2 | 2025 | 621 | 0.680 |
Why?
| | Faculty, Medical | 1 | 2024 | 296 | 0.680 |
Why?
| | Marijuana Abuse | 5 | 2017 | 232 | 0.670 |
Why?
| | Decision Making | 7 | 2017 | 966 | 0.660 |
Why?
| | Vaping | 1 | 2022 | 66 | 0.660 |
Why?
| | Tobacco Products | 1 | 2022 | 91 | 0.660 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 109 | 0.630 |
Why?
| | Humans | 81 | 2026 | 144748 | 0.630 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 245 | 0.610 |
Why?
| | Male | 58 | 2026 | 72211 | 0.600 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 49 | 0.600 |
Why?
| | Magnetic Resonance Imaging | 16 | 2025 | 3834 | 0.580 |
Why?
| | Female | 54 | 2026 | 78074 | 0.560 |
Why?
| | Education, Medical | 1 | 2021 | 275 | 0.550 |
Why?
| | Gray Matter | 2 | 2015 | 88 | 0.530 |
Why?
| | Nerve Net | 2 | 2025 | 278 | 0.500 |
Why?
| | Gift Giving | 1 | 2016 | 9 | 0.480 |
Why?
| | Case-Control Studies | 11 | 2023 | 3644 | 0.480 |
Why?
| | Affective Symptoms | 1 | 2016 | 56 | 0.460 |
Why?
| | Physicians | 1 | 2024 | 941 | 0.460 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2014 | 2190 | 0.450 |
Why?
| | Depression | 2 | 2024 | 1519 | 0.440 |
Why?
| | Reward | 4 | 2025 | 256 | 0.420 |
Why?
| | Suicide | 1 | 2021 | 687 | 0.410 |
Why?
| | Problem Behavior | 1 | 2015 | 106 | 0.410 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 143 | 0.370 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 21 | 0.360 |
Why?
| | Alcohol Drinking | 4 | 2023 | 856 | 0.350 |
Why?
| | Marijuana Smoking | 2 | 2014 | 262 | 0.350 |
Why?
| | Psychomotor Performance | 1 | 2013 | 325 | 0.330 |
Why?
| | United States | 13 | 2024 | 15694 | 0.320 |
Why?
| | Sex Characteristics | 3 | 2023 | 791 | 0.320 |
Why?
| | Ethanol | 2 | 2023 | 643 | 0.310 |
Why?
| | Receptors, Dopamine D2 | 2 | 2007 | 96 | 0.300 |
Why?
| | Marijuana Use | 2 | 2025 | 222 | 0.290 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2009 | 240 | 0.280 |
Why?
| | Mental Health | 3 | 2025 | 776 | 0.270 |
Why?
| | Legislation, Drug | 2 | 2022 | 80 | 0.270 |
Why?
| | Games, Experimental | 2 | 2019 | 12 | 0.270 |
Why?
| | Tegafur | 1 | 2026 | 7 | 0.240 |
Why?
| | Oxonic Acid | 1 | 2026 | 9 | 0.240 |
Why?
| | Neuroimaging | 3 | 2019 | 286 | 0.240 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2026 | 11 | 0.240 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 125 | 0.240 |
Why?
| | Literacy | 1 | 2026 | 14 | 0.240 |
Why?
| | Aggression | 2 | 2009 | 194 | 0.240 |
Why?
| | Amphetamine-Related Disorders | 2 | 2025 | 47 | 0.240 |
Why?
| | Corneal Diseases | 1 | 2026 | 47 | 0.240 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2026 | 97 | 0.230 |
Why?
| | Adult | 25 | 2026 | 40359 | 0.230 |
Why?
| | Reproducibility of Results | 5 | 2023 | 3403 | 0.230 |
Why?
| | Curriculum | 2 | 2026 | 1064 | 0.230 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 110 | 0.230 |
Why?
| | Young Adult | 9 | 2024 | 14021 | 0.220 |
Why?
| | Monitoring, Ambulatory | 1 | 2006 | 90 | 0.220 |
Why?
| | Child | 13 | 2025 | 22928 | 0.220 |
Why?
| | Colorado | 9 | 2020 | 4704 | 0.220 |
Why?
| | Brain Mapping | 5 | 2019 | 537 | 0.220 |
Why?
| | Substance Abuse Detection | 1 | 2006 | 104 | 0.210 |
Why?
| | Polymorphism, Genetic | 2 | 2006 | 626 | 0.210 |
Why?
| | Methamphetamine | 1 | 2025 | 70 | 0.210 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 774 | 0.210 |
Why?
| | Guilt | 1 | 2023 | 11 | 0.200 |
Why?
| | Charities | 1 | 2023 | 13 | 0.200 |
Why?
| | Reaction Time | 1 | 2025 | 434 | 0.200 |
Why?
| | Marriage | 1 | 2004 | 122 | 0.200 |
Why?
| | Central Nervous System Stimulants | 1 | 2025 | 182 | 0.190 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 324 | 0.190 |
Why?
| | Siblings | 3 | 2009 | 217 | 0.190 |
Why?
| | Happiness | 1 | 2022 | 24 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 235 | 0.180 |
Why?
| | Odds Ratio | 2 | 2020 | 1061 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 348 | 0.180 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1264 | 0.180 |
Why?
| | Impulsive Behavior | 2 | 2015 | 150 | 0.180 |
Why?
| | Cannabidiol | 1 | 2024 | 133 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 153 | 0.180 |
Why?
| | Unsafe Sex | 2 | 2020 | 63 | 0.180 |
Why?
| | Deep Brain Stimulation | 1 | 2025 | 211 | 0.180 |
Why?
| | Electronics | 1 | 2022 | 74 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 2 | 2008 | 2444 | 0.170 |
Why?
| | Prevalence | 7 | 2024 | 2849 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 319 | 0.170 |
Why?
| | Education, Medical, Graduate | 1 | 2026 | 552 | 0.170 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5797 | 0.170 |
Why?
| | Family | 4 | 2009 | 687 | 0.160 |
Why?
| | Enuresis | 1 | 2000 | 3 | 0.160 |
Why?
| | Double-Blind Method | 1 | 2025 | 2022 | 0.160 |
Why?
| | Phenotype | 4 | 2010 | 3236 | 0.160 |
Why?
| | Educational Measurement | 1 | 2023 | 332 | 0.150 |
Why?
| | Biomedical Research | 1 | 2026 | 706 | 0.150 |
Why?
| | Social Stigma | 1 | 2021 | 152 | 0.150 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 72 | 0.150 |
Why?
| | Substance Abuse, Intravenous | 2 | 2013 | 125 | 0.150 |
Why?
| | Data Collection | 2 | 2014 | 658 | 0.150 |
Why?
| | Tobacco Use | 1 | 2020 | 66 | 0.150 |
Why?
| | Fear | 1 | 2022 | 349 | 0.150 |
Why?
| | Craving | 1 | 2019 | 39 | 0.150 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 8 | 0.150 |
Why?
| | Education, Distance | 1 | 2019 | 61 | 0.150 |
Why?
| | Logistic Models | 3 | 2020 | 2111 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 89 | 0.140 |
Why?
| | Multimodal Imaging | 1 | 2019 | 121 | 0.140 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 151 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2005 | 892 | 0.140 |
Why?
| | Tuberculin Test | 1 | 1998 | 36 | 0.140 |
Why?
| | Sex Factors | 4 | 2017 | 2101 | 0.140 |
Why?
| | Linkage Disequilibrium | 3 | 2008 | 254 | 0.140 |
Why?
| | Sleep | 1 | 2025 | 915 | 0.130 |
Why?
| | Automobile Driving | 1 | 2020 | 155 | 0.130 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1998 | 131 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 192 | 0.130 |
Why?
| | Clinical Competence | 2 | 2023 | 1252 | 0.130 |
Why?
| | Genotype | 4 | 2014 | 1878 | 0.130 |
Why?
| | Writing | 1 | 2018 | 99 | 0.120 |
Why?
| | Comorbidity | 7 | 2015 | 1685 | 0.120 |
Why?
| | Organ Size | 2 | 2015 | 481 | 0.120 |
Why?
| | Violence | 1 | 2019 | 283 | 0.120 |
Why?
| | Surveys and Questionnaires | 6 | 2018 | 6062 | 0.120 |
Why?
| | Drug Prescriptions | 1 | 2018 | 273 | 0.120 |
Why?
| | Risk Factors | 7 | 2026 | 10739 | 0.120 |
Why?
| | Moral Obligations | 1 | 2016 | 15 | 0.120 |
Why?
| | California | 1 | 2017 | 472 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 527 | 0.120 |
Why?
| | Photic Stimulation | 1 | 2017 | 260 | 0.120 |
Why?
| | Suicide, Attempted | 1 | 2020 | 405 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 26 | 0.120 |
Why?
| | Research Subjects | 1 | 2015 | 43 | 0.120 |
Why?
| | Suicidal Ideation | 1 | 2021 | 564 | 0.120 |
Why?
| | Psychotic Disorders | 1 | 1998 | 182 | 0.120 |
Why?
| | Genetics, Population | 2 | 2007 | 218 | 0.120 |
Why?
| | Self Report | 2 | 2020 | 875 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2000 | 321 | 0.110 |
Why?
| | Parents | 1 | 2004 | 1468 | 0.110 |
Why?
| | Internship and Residency | 1 | 2026 | 1256 | 0.110 |
Why?
| | Gambling | 1 | 2015 | 32 | 0.110 |
Why?
| | Frontal Lobe | 2 | 2015 | 161 | 0.110 |
Why?
| | Biological Specimen Banks | 1 | 2015 | 100 | 0.110 |
Why?
| | Learning | 1 | 2019 | 443 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2018 | 702 | 0.100 |
Why?
| | Informed Consent | 1 | 2015 | 196 | 0.100 |
Why?
| | Middle Aged | 12 | 2026 | 35640 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2007 | 69 | 0.090 |
Why?
| | Juvenile Delinquency | 3 | 2008 | 107 | 0.090 |
Why?
| | Accidents, Traffic | 1 | 2014 | 192 | 0.090 |
Why?
| | Limbic System | 1 | 2012 | 56 | 0.090 |
Why?
| | Attitude | 1 | 2014 | 258 | 0.090 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2019 | 153 | 0.090 |
Why?
| | Longitudinal Studies | 5 | 2014 | 3042 | 0.090 |
Why?
| | DNA Primers | 2 | 2010 | 519 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5345 | 0.080 |
Why?
| | Genomics | 1 | 2015 | 829 | 0.080 |
Why?
| | Hawaii | 1 | 2010 | 42 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1144 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 56 | 0.080 |
Why?
| | Age Factors | 2 | 2014 | 3336 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 492 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 499 | 0.070 |
Why?
| | Urban Population | 1 | 2012 | 493 | 0.070 |
Why?
| | Receptors, Serotonin | 2 | 2000 | 35 | 0.070 |
Why?
| | Base Sequence | 2 | 2010 | 2201 | 0.070 |
Why?
| | Diseases in Twins | 1 | 2009 | 159 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1797 | 0.070 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 63 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 14 | 0.070 |
Why?
| | Acculturation | 1 | 2007 | 53 | 0.070 |
Why?
| | Mouth Mucosa | 1 | 2007 | 91 | 0.060 |
Why?
| | Taq Polymerase | 1 | 2006 | 10 | 0.060 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 164 | 0.060 |
Why?
| | Transcription, Genetic | 2 | 2007 | 1514 | 0.060 |
Why?
| | Inheritance Patterns | 1 | 2006 | 45 | 0.060 |
Why?
| | Twins, Monozygotic | 1 | 2007 | 192 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 152 | 0.060 |
Why?
| | Hospitals, Veterans | 1 | 2007 | 255 | 0.060 |
Why?
| | Water Loss, Insensible | 1 | 2006 | 4 | 0.060 |
Why?
| | Japan | 1 | 2026 | 141 | 0.060 |
Why?
| | Residential Treatment | 1 | 2006 | 28 | 0.060 |
Why?
| | Breath Tests | 1 | 2006 | 78 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 814 | 0.060 |
Why?
| | Demography | 1 | 2006 | 297 | 0.060 |
Why?
| | Regression Analysis | 1 | 2007 | 1014 | 0.060 |
Why?
| | Alcoholic Intoxication | 1 | 2006 | 74 | 0.050 |
Why?
| | Drug Combinations | 1 | 2026 | 386 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2006 | 237 | 0.050 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 1222 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2006 | 597 | 0.050 |
Why?
| | Hospitals, University | 1 | 2004 | 176 | 0.050 |
Why?
| | Acute Coronary Syndrome | 1 | 2007 | 286 | 0.050 |
Why?
| | Alleles | 1 | 2007 | 895 | 0.050 |
Why?
| | Equipment Design | 1 | 2006 | 535 | 0.050 |
Why?
| | Twins | 1 | 2025 | 225 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 777 | 0.050 |
Why?
| | Smoking | 2 | 2012 | 1583 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 434 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2026 | 8103 | 0.050 |
Why?
| | Incidence | 2 | 2026 | 2864 | 0.050 |
Why?
| | Canada | 1 | 2024 | 432 | 0.050 |
Why?
| | DNA | 2 | 2007 | 1458 | 0.050 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 689 | 0.050 |
Why?
| | Aged | 5 | 2026 | 25564 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2061 | 0.040 |
Why?
| | Prospective Studies | 3 | 2026 | 7956 | 0.040 |
Why?
| | Psychometrics | 3 | 2009 | 746 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2012 | 97 | 0.040 |
Why?
| | Substance Abuse Treatment Centers | 2 | 2012 | 47 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2000 | 75 | 0.040 |
Why?
| | Receptors, LDL | 1 | 1998 | 53 | 0.040 |
Why?
| | Child Abuse | 1 | 2004 | 557 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2024 | 592 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 65 | 0.030 |
Why?
| | HIV Infections | 1 | 2013 | 3039 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 157 | 0.030 |
Why?
| | Tonsillectomy | 1 | 2000 | 102 | 0.030 |
Why?
| | Attention | 1 | 2021 | 458 | 0.030 |
Why?
| | Health Surveys | 2 | 2012 | 512 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 313 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 96 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 77 | 0.030 |
Why?
| | Cues | 1 | 2019 | 326 | 0.030 |
Why?
| | Anxiety | 1 | 2024 | 1098 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2953 | 0.030 |
Why?
| | Game Theory | 1 | 2015 | 7 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2015 | 22 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2018 | 211 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7074 | 0.030 |
Why?
| | Genetic Variation | 1 | 1998 | 1012 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1993 | 0.020 |
Why?
| | Condoms | 1 | 2013 | 101 | 0.020 |
Why?
| | Radiography | 1 | 2015 | 847 | 0.020 |
Why?
| | Heroin Dependence | 1 | 2012 | 33 | 0.020 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 94 | 0.020 |
Why?
| | Family Conflict | 1 | 2012 | 43 | 0.020 |
Why?
| | Sexual Partners | 1 | 2013 | 191 | 0.020 |
Why?
| | Schizophrenia | 1 | 1996 | 445 | 0.020 |
Why?
| | Family Relations | 1 | 2012 | 90 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2012 | 136 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7211 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1063 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 308 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 11498 | 0.020 |
Why?
| | Social Environment | 1 | 2012 | 302 | 0.020 |
Why?
| | Patient Admission | 1 | 2012 | 209 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1372 | 0.020 |
Why?
| | Cerebellum | 1 | 2011 | 225 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2007 | 16942 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1514 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 141 | 0.020 |
Why?
| | Receptor, Serotonin, 5-HT2A | 2 | 2000 | 18 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2012 | 1118 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 960 | 0.020 |
Why?
| | Sex Distribution | 1 | 2007 | 383 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3595 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 377 | 0.010 |
Why?
| | Age of Onset | 1 | 2006 | 559 | 0.010 |
Why?
| | Health Services Research | 1 | 2007 | 403 | 0.010 |
Why?
| | Models, Genetic | 1 | 2007 | 593 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1333 | 0.010 |
Why?
| | Nicotine | 1 | 2006 | 343 | 0.010 |
Why?
| | Perception | 1 | 2006 | 380 | 0.010 |
Why?
| | Schools | 1 | 2006 | 460 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 2007 | 744 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2007 | 966 | 0.010 |
Why?
| | Molecular Sequence Data | 2 | 1998 | 2944 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1505 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1825 | 0.010 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2000 | 8 | 0.010 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2000 | 14 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1074 | 0.010 |
Why?
| | Threonine | 1 | 1998 | 47 | 0.010 |
Why?
| | Cricetinae | 1 | 1998 | 301 | 0.010 |
Why?
| | Glycosylation | 1 | 1998 | 173 | 0.010 |
Why?
| | Organ Specificity | 1 | 1998 | 312 | 0.010 |
Why?
| | Serine | 1 | 1998 | 149 | 0.010 |
Why?
| | Rabbits | 1 | 1998 | 666 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 994 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1998 | 245 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 950 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1998 | 479 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1372 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 2168 | 0.010 |
Why?
| | Myocardium | 1 | 1998 | 932 | 0.010 |
Why?
| | Cell Line | 1 | 1998 | 2900 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1998 | 1802 | 0.000 |
Why?
| | Animals | 1 | 1998 | 38224 | 0.000 |
Why?
|
|
Sakai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|